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In this issue ofCell Metabolism, Liao and colleagues have applied a novel synthetic approach to fight obesity
in animals by engineering the plant glyoxylate shunt in vivo (Dean et al., 2009). The idea of introducing an
entirely foreign metabolic pathway opens up opportunities for understanding metabolism and creating novel
potential therapeutic approaches.Obesity has become a worldwide pan-
demic in recent years due to a global trend
toward increased energy-dense food
intake and decreased physical activity. In
2005, approximately 1.6 billion adults
were overweight and 400 million were
obese (World Health Organization, 2006).
Current interventions for obesity include
diet, exercise, and bariatric surgery. With
our increased understanding of the patho-
physiology of obesity over the past 2
decades, multiple mechanisms have
been explored to design ‘‘magic pills’’
that can treat obesity and its complica-
tions. These include appetite suppres-
sants, absorption inhibitors, and exercise
and thermogenesis mimetics that either
reduce food intake or increase energy
expenditure (Flier, 2004; Narkar et al.,
2008; Seale et al., 2009). Now, Dean
et al. (2009) explore the idea of engi-
neering both cells and animals with a
non-native metabolic pathway, which
holds promise for the treatment of obesity
and related disorders.
It has long been known that vertebrates
and insects can turn excess dietary
sugar into fat, but are unable to turn fat
into sugar. However, plants and certain
microorganisms have the capability to
utilize the so-called glyoxylate shunt to
synthesize carbohydrates from fat. Two
distinct enzymes mediate this pathway:
(1) isocitrate lyase that cleaves isocitrate
into succinate and glyoxylate (hence
the name); and (2) malate synthase,
which makes malate from glyoxylate and
acetyl-CoA (Figure 1). Malate can then
be further oxidized to form phosphoenol-
pyruvate. In plants and some micro-
organisms, this eventually generates
carbohydrate through gluconeogenesis.
Thus, the glyoxylate shunt provides an
added exit for the oxidation and catabo-
lism of acetyl-CoA and potentially fat, asacetyl-CoA is the end product of fatty
acid b-oxidation.
Eyeing the potential fat-degrading
benefits of the glyoxylate shunt and
the fact that only two enzymes are essen-
tial for the whole pathway, Liao and
colleagues introduced the glyoxylate
shunt into human hepatic cells and mouse
livers to examine its impact on mamma-
lian fat metabolism. Due to the complexity
of nutrient homeostasis and signal cross-
talk in mammals, the metabolic outcome
of this intervention was, a priori, uncertain.
For example, gluconeogenesis could be
activated in mice as it is in plants and
bacteria, but might this extra ‘‘synthetic’’
route tap the adipose store and speed
up fatty acid degradation?
When the authors constitutively ex-
pressed the E. coli version of both
isocitrate lyase (aceA) and malate syn-
thase (aceB) in human HepG2 hepato-
cytes (ACE cells), they found these cells
to have increased uptake of palmitate,
which appears to be oxidized at about
a 2-fold increased rate compared to
controls. Importantly and intriguingly,
the increased palmitate uptake is not
used for gluconeogenesis. Consistent
with these observations, microarray ana-
lysis showed that the expression levels
of many genes involved in fatty acid
oxidation such as CPT1a are increased.
Conversely, genes involved in fatty acid
and triglyceride synthesis show reduced
expression. This is likely due to markedly
increased AMPK activity in these cells as
suggested by increased phosphorylation
of both AMPK and ACC.
With these exciting in vitro observa-
tions, the authors next investigated the
in vivo effect of a synthetic glyoxylate
shunt by expressing aceA and aceB in
mouse liver (ACE mice). Both male and
female ACE mice are resistant to highCell Metabolifat diet-induced weight gain and have
less fat mass compared to controls after
6 weeks on a high-fat diet. Intriguingly,
female ACE mice appear to benefit
more, with significant reduction in body
fat percentage, visceral fat, serum leptin,
liver and plasma triglyceride, plasma total
cholesterol, and ketone bodies, while
food intake remained the same. Plasma
free fatty acid and glucose levels did not
change, which is good news, as it
suggests that the increased fat catabo-
lism will not increase blood glucose levels
and exacerbate the diabetic complica-
tions associated with obesity. The female
ACE mice also had decreased liver
malonyl-CoA and ATP levels, which is
consistent with increased liver CPT1a
expression and potentially explains the
observation of AMPK activation in vitro.
Metabolic cage studies revealed that the
respiratory exchange ratios in female
ACE mice are significantly reduced, indi-
cating increased use of fat rather than
glucose as an energy source in vivo.
Despite similar activity levels, the energy
expenditure in ACE mice is increased
during their resting phase as well as the
entire 24 hr period.
Could these results ultimately be
translated from bench to bedside? The
glyoxylate pathway could potentially
be engineered by introducing the two
key enzymes through a gene therapy
approach, provided that these exogenous
proteins elicit no adverse immune
responses. Alternatively, chemicals that
activate or stimulate the activity of glyox-
ylate shunt enzymes could be used as
mimetics. Despite the long-standing
belief that the glyoxylate pathway only
exists in plants, microorganisms, and
certain nematodes, some earlier studies
reported that glyoxylate enzyme activity
could be detected in chicken and ratsm 9, June 3, 2009 ª2009 Elsevier Inc. 483
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PreviewsFigure 1. One of the Shared Features of TCA Cycle and Glyoxylate Shunt Is the Degradation of Acetyl-CoA to Form Carbon Dioxide
Fatty acid is transported from cytosol to mitochondria and generates acetyl-CoA through b-oxidation. Acetyl-CoA enters tricarboxylic acid cycle (TCA or Krebs
cycle, illustrated by the green arrows) and is oxidized to form carbon dioxide. The glyoxylate shunt is illustrated by the pink arrows. Glyoxylate and acetyle-CoA
could form malate, which can then be decarboxylated to generate carbon dioxide as well.livers, although no highly homologous
genes have been identified in vertebrates
(Davis et al., 1990, 1989). Also noteworthy
is that vitamin D was reported to stimulate
the activity of these glyoxylate enzymes
as well as fatty acid oxidation.
The current studybyLiaoand colleagues
is a beautiful example of proof-of-principle
studies of bioengineering. Not only can we
use the knowledge of biology to engineer
biomaterials and biofuels, but we can also
employ an engineering approach in higher484 Cell Metabolism 9, June 3, 2009 ª2009organisms using synthetic physiology to
probe basic biomedical questions and
look for potential medical treatments for
human diseases.
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